• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌细胞和免疫细胞在癌症起始、进展和转移过程中的代谢

Metabolism of cancer cells and immune cells in the initiation, progression, and metastasis of cancer.

作者信息

Jiang Mingxia, Fang Huapan, Tian Huayu

机构信息

State Key Laboratory of Physical Chemistry of Solid Surfaces, College of Chemistry and Chemical Engineering, Innovation Laboratory for Sciences and Technologies of Energy Materials of Fujian Province (IKKEM), Xiamen University, Xiamen 361005, China.

Shenzhen Research Institute of Xiamen University, Shenzhen 518000, China.

出版信息

Theranostics. 2025 Jan 1;15(1):155-188. doi: 10.7150/thno.103376. eCollection 2025.

DOI:10.7150/thno.103376
PMID:39744225
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11667227/
Abstract

The metabolism of cancer and immune cells plays a crucial role in the initiation, progression, and metastasis of cancer. Cancer cells often undergo metabolic reprogramming to sustain their rapid growth and proliferation, along with meeting their energy demands and biosynthetic needs. Nevertheless, immune cells execute their immune response functions through the specific metabolic pathways, either to recognize, attack, and eliminate cancer cells or to promote the growth or metastasis of cancer cells. The alteration of cancer niches will impact the metabolism of both cancer and immune cells, modulating the survival and proliferation of cancer cells, and the activation and efficacy of immune cells. This review systematically describes the key characteristics of cancer cell metabolism and elucidates how such metabolic traits influence the metabolic behavior of immune cells. Moreover, this article also highlights the crucial role of immune cell metabolism in anti-tumor immune responses, particularly in priming T cell activation and function. By comprehensively exploring the metabolic crosstalk between cancer and immune cells in cancer niche, the aim is to discover novel strategies of cancer immunotherapy and provide effective guidance for clinical research in cancer treatment. In addition, the review also discusses current challenges such as the inadequacy of relevant diagnostic technologies and the issue of multidrug resistance, and proposes potential solutions including bolstering foundational cancer research, fostering technological innovation, and implementing precision medicine approaches. In-depth research into the metabolic effects of cancer niches can improve cancer treatment outcomes, prolong patients' survival period and enhance their quality of life.

摘要

癌症细胞与免疫细胞的代谢在癌症的发生、发展和转移过程中起着至关重要的作用。癌细胞常经历代谢重编程,以维持其快速生长和增殖,同时满足其能量需求和生物合成需求。然而,免疫细胞通过特定的代谢途径执行其免疫反应功能,要么识别、攻击和消除癌细胞,要么促进癌细胞的生长或转移。癌症微环境的改变会影响癌细胞和免疫细胞的代谢,调节癌细胞的存活和增殖以及免疫细胞的激活和功效。本综述系统地描述了癌细胞代谢的关键特征,并阐明了这些代谢特性如何影响免疫细胞的代谢行为。此外,本文还强调了免疫细胞代谢在抗肿瘤免疫反应中的关键作用,特别是在启动T细胞激活和功能方面。通过全面探索癌症微环境中癌细胞与免疫细胞之间的代谢相互作用,旨在发现癌症免疫治疗的新策略,并为癌症治疗的临床研究提供有效指导。此外,该综述还讨论了当前面临的挑战,如相关诊断技术的不足和多药耐药问题,并提出了潜在的解决方案,包括加强基础癌症研究、促进技术创新和实施精准医学方法。深入研究癌症微环境的代谢效应可以改善癌症治疗效果,延长患者生存期并提高其生活质量。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fea4/11667227/70043e845883/thnov15p0155g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fea4/11667227/a2590ed5680a/thnov15p0155g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fea4/11667227/90d79ec6bd27/thnov15p0155g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fea4/11667227/d91c79233843/thnov15p0155g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fea4/11667227/fed0f3260540/thnov15p0155g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fea4/11667227/a8d282cd0f24/thnov15p0155g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fea4/11667227/48e8cd1cbedb/thnov15p0155g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fea4/11667227/eede68e6e63c/thnov15p0155g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fea4/11667227/dc2468c1d6e9/thnov15p0155g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fea4/11667227/4ca5eaa88f09/thnov15p0155g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fea4/11667227/70043e845883/thnov15p0155g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fea4/11667227/a2590ed5680a/thnov15p0155g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fea4/11667227/90d79ec6bd27/thnov15p0155g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fea4/11667227/d91c79233843/thnov15p0155g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fea4/11667227/fed0f3260540/thnov15p0155g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fea4/11667227/a8d282cd0f24/thnov15p0155g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fea4/11667227/48e8cd1cbedb/thnov15p0155g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fea4/11667227/eede68e6e63c/thnov15p0155g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fea4/11667227/dc2468c1d6e9/thnov15p0155g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fea4/11667227/4ca5eaa88f09/thnov15p0155g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fea4/11667227/70043e845883/thnov15p0155g010.jpg

相似文献

1
Metabolism of cancer cells and immune cells in the initiation, progression, and metastasis of cancer.癌细胞和免疫细胞在癌症起始、进展和转移过程中的代谢
Theranostics. 2025 Jan 1;15(1):155-188. doi: 10.7150/thno.103376. eCollection 2025.
2
Harnessing Metabolic Reprogramming to Improve Cancer Immunotherapy.利用代谢重编程来改善癌症免疫疗法。
Int J Mol Sci. 2021 Sep 24;22(19):10268. doi: 10.3390/ijms221910268.
3
Metabolic Reprogramming of Immune Cells in the Tumor Microenvironment.肿瘤微环境中免疫细胞的代谢重编程。
Int J Mol Sci. 2024 Nov 14;25(22):12223. doi: 10.3390/ijms252212223.
4
Metabolic reprogramming of tumor microenviroment by engineered bacteria.工程菌对肿瘤微环境的代谢重编程
Semin Cancer Biol. 2025 Jul;112:58-70. doi: 10.1016/j.semcancer.2025.03.003. Epub 2025 Mar 27.
5
Metabolic reprogramming in tumor immune microenvironment: Impact on immune cell function and therapeutic implications.肿瘤免疫微环境中的代谢重编程:对免疫细胞功能的影响及其治疗意义。
Cancer Lett. 2024 Aug 10;597:217076. doi: 10.1016/j.canlet.2024.217076. Epub 2024 Jun 19.
6
Metabolic reprogramming and immunological changes in the microenvironment of esophageal cancer: future directions and prospects.食管癌微环境中的代谢重编程与免疫变化:未来方向与前景
Front Immunol. 2025 Jan 24;16:1524801. doi: 10.3389/fimmu.2025.1524801. eCollection 2025.
7
Immunometabolism: A new target for improving cancer immunotherapy.免疫代谢:改善癌症免疫疗法的新靶点。
Adv Cancer Res. 2019;143:195-253. doi: 10.1016/bs.acr.2019.03.004. Epub 2019 Apr 17.
8
Immune-mediated anti-tumor effects of metformin; targeting metabolic reprogramming of T cells as a new possible mechanism for anti-cancer effects of metformin.二甲双胍的免疫介导抗肿瘤作用;靶向 T 细胞的代谢重编程作为二甲双胍抗肿瘤作用的新可能机制。
Biochem Pharmacol. 2020 Apr;174:113787. doi: 10.1016/j.bcp.2019.113787. Epub 2019 Dec 27.
9
Tumor-induced metabolic immunosuppression: Mechanisms and therapeutic targets.肿瘤诱导的代谢性免疫抑制:机制与治疗靶点。
Cell Rep. 2025 Jan 28;44(1):115206. doi: 10.1016/j.celrep.2024.115206. Epub 2025 Jan 10.
10
Targeting T cell metabolism in the tumor microenvironment: an anti-cancer therapeutic strategy.靶向肿瘤微环境中的 T 细胞代谢:一种抗癌治疗策略。
J Exp Clin Cancer Res. 2019 Sep 13;38(1):403. doi: 10.1186/s13046-019-1409-3.

引用本文的文献

1
The nutritional equation: decoding diet's influence on breast cancer risk and progression - a perspective.营养方程式:解读饮食对乳腺癌风险和进展的影响——一种观点
Ann Med Surg (Lond). 2025 Jul 18;87(9):5528-5534. doi: 10.1097/MS9.0000000000003612. eCollection 2025 Sep.
2
Ultrasound-activated miR-195-5p/shikonin nanobubbles remodel immunosuppressive microenvironment immunogenic cell death to potentiate PD-1/PD-L1 blockade in hepatocellular carcinoma.超声激活的miR-195-5p/紫草素纳米气泡重塑免疫抑制微环境并诱导免疫原性细胞死亡,以增强肝细胞癌中PD-1/PD-L1阻断疗法的效果。
Mater Today Bio. 2025 Aug 18;34:102216. doi: 10.1016/j.mtbio.2025.102216. eCollection 2025 Oct.
3

本文引用的文献

1
Recent Advances in Degradable Biomedical Polymers for Prevention, Diagnosis and Treatment of Diseases.可降解生物医用聚合物在疾病的预防、诊断和治疗中的最新进展。
Biomacromolecules. 2024 Nov 11;25(11):7015-7057. doi: 10.1021/acs.biomac.4c01193. Epub 2024 Oct 17.
2
Unlocking the multifaceted molecular functions and diverse disease implications of lactylation.揭示乳酰化的多方面分子功能及多种疾病关联。
Biol Rev Camb Philos Soc. 2025 Feb;100(1):172-189. doi: 10.1111/brv.13135. Epub 2024 Sep 16.
3
Mechano-YAP/TAZ-regulated smooth muscle cells are an important source of Wnt signalling for gut regeneration.
Exploring the critical role of SDHA in breast cancer proliferation: implications for novel therapeutic strategies.
探索SDHA在乳腺癌增殖中的关键作用:对新型治疗策略的启示
Am J Transl Res. 2025 Jul 15;17(7):5221-5240. doi: 10.62347/XAKQ8090. eCollection 2025.
4
Identification of CD4_Naive cells related gene FMO4 as a positive regulator of the poor prognosis of septic CRC patients.鉴定CD4幼稚细胞相关基因FMO4作为脓毒症性结直肠癌患者预后不良的正向调节因子。
Cancer Cell Int. 2025 Jul 28;25(1):285. doi: 10.1186/s12935-025-03917-5.
5
Impaired natural killer cell maturation in lung adenocarcinoma driven by and downregulation through disrupted lipid metabolism.由脂质代谢紊乱导致的[具体因素1]和[具体因素2]下调所驱动的肺腺癌中自然杀伤细胞成熟受损。
Transl Lung Cancer Res. 2025 May 30;14(5):1660-1676. doi: 10.21037/tlcr-24-1027. Epub 2025 May 27.
6
Lactate-mediated metabolic reprogramming of tumor-associated macrophages: implications for tumor progression and therapeutic potential.乳酸介导的肿瘤相关巨噬细胞代谢重编程:对肿瘤进展和治疗潜力的影响。
Front Immunol. 2025 May 13;16:1573039. doi: 10.3389/fimmu.2025.1573039. eCollection 2025.
7
Cytokine-mediated regulation of immune cell metabolic pathways in the tumor microenvironment.细胞因子介导的肿瘤微环境中免疫细胞代谢途径的调控
Naunyn Schmiedebergs Arch Pharmacol. 2025 Apr 12. doi: 10.1007/s00210-025-04133-8.
8
Integrated m6A RNA methylation and transcriptomic analysis of Apostichopus japonicus under combined high-temperature and hypoxia stress.高温和缺氧联合胁迫下刺参的m6A RNA甲基化与转录组整合分析
BMC Genomics. 2025 Apr 10;26(1):363. doi: 10.1186/s12864-025-11532-x.
9
Integrative bioinformatics analysis of high-throughput sequencing and in vitro functional analysis leads to uncovering key hub genes in esophageal squamous cell carcinoma.高通量测序的整合生物信息学分析与体外功能分析有助于揭示食管鳞状细胞癌中的关键枢纽基因。
Hereditas. 2025 Mar 14;162(1):38. doi: 10.1186/s41065-025-00398-4.
10
Current advancement of immune function paradox of tumour-infiltrating cells and their immunotherapeutic targets: a mini-review.肿瘤浸润细胞免疫功能悖论及其免疫治疗靶点的当前进展:一篇综述。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Mar 10. doi: 10.1007/s00210-025-03985-4.
机械力调控的YAP/TAZ信号通路调节的平滑肌细胞是肠道再生过程中Wnt信号的重要来源。
Clin Transl Med. 2024 Aug;14(8):e70005. doi: 10.1002/ctm2.70005.
4
Targeting cytokine and chemokine signaling pathways for cancer therapy.针对细胞因子和趋化因子信号通路的癌症治疗。
Signal Transduct Target Ther. 2024 Jul 22;9(1):176. doi: 10.1038/s41392-024-01868-3.
5
Influence of TP53 mutation on efficacy and survival in advanced EGFR-mutant non-small cell lung cancer patients treated with third-generation EGFR tyrosine kinase inhibitors.TP53突变对接受第三代EGFR酪氨酸激酶抑制剂治疗的晚期EGFR突变非小细胞肺癌患者疗效和生存的影响。
MedComm (2020). 2024 Jun 2;5(6):e586. doi: 10.1002/mco2.586. eCollection 2024 Jun.
6
Metabolic reprogramming in liver fibrosis.肝纤维化中的代谢重编程。
Cell Metab. 2024 Jul 2;36(7):1439-1455. doi: 10.1016/j.cmet.2024.05.003. Epub 2024 May 31.
7
mRNA vaccines contribute to innate and adaptive immunity to enhance immune response in vivo.mRNA 疫苗有助于先天和适应性免疫,增强体内免疫反应。
Biomaterials. 2024 Oct;310:122628. doi: 10.1016/j.biomaterials.2024.122628. Epub 2024 May 28.
8
A 5:2 intermittent fasting regimen ameliorates NASH and fibrosis and blunts HCC development via hepatic PPARα and PCK1.5:2 间歇性禁食方案通过肝脏 PPARα 和 PCK1 改善 NASH 和肝纤维化,并减缓 HCC 的发展。
Cell Metab. 2024 Jun 4;36(6):1371-1393.e7. doi: 10.1016/j.cmet.2024.04.015. Epub 2024 May 7.
9
Dietary intake and glutamine-serine metabolism control pathologic vascular stiffness.饮食摄入和谷氨酰胺-丝氨酸代谢控制病理性血管僵硬。
Cell Metab. 2024 Jun 4;36(6):1335-1350.e8. doi: 10.1016/j.cmet.2024.04.010. Epub 2024 May 2.
10
Cancer cell metabolism and antitumour immunity.癌细胞代谢与抗肿瘤免疫。
Nat Rev Immunol. 2024 Sep;24(9):654-669. doi: 10.1038/s41577-024-01026-4. Epub 2024 Apr 22.